| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |